Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9579105 | 0.98 | — | — | |
| SCHEMBL7707533 | 0.81 | NAAA (0.37) | LMNAALDH1A1MAPTPTGS2TDP1 | |
| SCHEMBL9420755 | 0.79 | TSHR (0.44) | LMNAALDH1A1MAPTPTGS2TDP1 | |
| SCHEMBL3253032 | 0.79 | TP53 (0.33) | LMNAMAPTKDM4ECYP1A2 | |
| SCHEMBL1537296 | 0.79 | GRIN2D (0.33) | LMNAKDM4ECYP1A2 | |
| SCHEMBL186138 | 0.79 | GRIN2D (0.33) | LMNAKDM4ECYP1A2 | |
| SCHEMBL8837532 | 0.78 | ENPEP (0.35) | — | |
| SCHEMBL4215424 | 0.77 | TP53 (0.32) | LMNAKDM4ECYP1A2 | |
| SCHEMBL3975721 | 0.77 | TP53 (0.32) | LMNAKDM4ECYP1A2 | |
| SCHEMBL4215465 | 0.77 | TP53 (0.32) | LMNAKDM4ECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105997878-A | Composite micelle carrier medicine composition for reducing free radical damage | 原创生医股份有限公司 | 2016-10-12 | — | — | CN | claimed |
| US-9226967-B2 | Chelating complex micelles drug carrier | Original BioMedicals Co., Ltd (TW) | 2016-01-05 | — | — | US | claimed |
| US-9220786-B2 | Pharmaceutical composition of chelating complex micelles | Original BioMedicals Co., Ltd (TW) | 2015-12-29 | — | — | US | claimed |
| US-9211341-B2 | Method of manufacturing a pharmaceutical composition having chelating type complex micelles | ORIGINAL BIOMEDICALS CO., LTD. (TW) | 2015-12-15 | — | — | US | claimed |
| CN-104114188-A | Composite micelle carrier medicine composition for reducing free radical damage | ORIGINAL BIOMEDICALS CO LTD | 2014-10-22 | — | — | CN | claimed |
| US-20140303329-A1 | Method of manufacturing a pharmaceutical composition having chelating type complex micelles | Original BioMedicals Co., Ltd (TW) | 2014-10-09 | — | — | US | claimed |
| US-20140296435-A1 | PHARMACEUTICAL COMPOSITION OF CHELATING COMPLEX MICELLES | Original BioMedicals Co., Ltd (TW) | 2014-10-02 | — | — | US | claimed |
| US-20140296451-A1 | CHELATING COMPLEX MICELLES DRUG CARRIER | Original BioMedicals Co., Ltd (TW) | 2014-10-02 | — | — | US | claimed |
| EP-2783679-A1 | DRUG CARRIER WITH CHELATING COMPOSITE MICELL AND USE THEREOF | Original BioMedicals Co., Ltd. (TW) | 2014-10-01 | — | — | EP | claimed |
| US-20130131283-A1 | Drug Carrier with Chelating Complex Micelles and the Application thereof | Original Biomedicals, Co., Ltd. (TW) | 2013-05-23 | — | — | US | claimed |
| WO-2011031284-A1 | POLYMERIC CARRIER COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS, METHODS OF MAKING AND USING THE SAME | PHARMAIN CORPORATION (US) | 2011-03-17 | — | — | WO | claimed |
| US-20100069293-A1 | POLYMERIC CARRIER COMPOSITIONS FOR DELIVERY OF ACTIVE AGENTS, METHODS OF MAKING AND USING THE SAME | PHARMAIN CORPORATION (US) | 2010-03-18 | — | — | US | claimed |
| EP-2026824-A2 | MULTIFUNCTIONAL BLOOD SUBSTITUTE | The United States Of America As Represented By the Sectretary of the Navy (US) | 2009-02-25 | — | — | EP | claimed |
| WO-2007136555-A2 | MULTIFUNCTIONAL BLOOD SUBSTITUTE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2007-11-29 | — | — | WO | claimed |
| US-20070265195-A1 | Multifunctional blood substitute | FREILICH DANIEL A | 2007-11-15 | — | — | US | claimed |
| EP-2783679-B1 | DRUG CARRIER WITH CHELATING COMPOSITE MICELLE AND USE THEREOF | ORIGINAL BIOMEDICALS CO LTD (TW) | 2018-07-18 | — | — | EP | disclosed |
| US-9795677-B2 | Method for reducing damage caused by free radicals | Original BioMedicals Co., Ltd (TW) | 2017-10-24 | — | — | US | disclosed |
| EP-0202081-A2 | A single step heterogeneous assay and kit | SYNTEX (U.S.A.) INC. (US) | 1986-11-20 | — | — | EP | disclosed |
| US-4356118-A | Tryptophan derivatives | G. D. SEARLE & CO. (US) | 1982-10-26 | — | — | US | disclosed |
| EP-0013261-A1 | Guaiacol esters of alpha- and beta-mercaptopropionylalanine and alpha- and beta-mercaptopropionylglycine, process for their preparation and pharmaceutical compositions containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1980-07-09 | — | — | EP | disclosed |